Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

Study ID: NCT07485920
Start Date: 2026-05-01
End Date: 2030-01-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

20

Intervention / Treatment

Tislelizumab and nintedanib

Sponsor

The Affiliated Hospital of Qingdao University

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Study ID: NCT07211438
Start Date: 2026-04-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Psilocybin

Sponsor

Centre for Addiction and Mental Health

Source: clinicaltrials.gov

Share:
Add to list

Opioid Dispenser for Microdiscectomy/Laminectomy

Study ID: NCT06358040
Start Date: 2026-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Opioid-Dispensing Device

App

Standard Opioid Pill Bottle

Sponsor

Hospital for Special Surgery, New York

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Study ID: NCT07403825
Start Date: 2026-04
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Vabysmo 6 MG in 0.05 ML Injection

Sponsor

Biobizkaia Health Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease

Study ID: NCT07186218
Start Date: 2026-05-01
End Date: 2030-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Electronic patient-reported outcome measure (ePROM) for symptom monitoring

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Novel Technologies to Measure Vision-related Quality of Life

Study ID: NCT07489898
Start Date: 2026-04
End Date: 2030-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Tablet- and virtual reality headset-based test of vision-related quality of life

Sponsor

Nisha Nixon

Source: clinicaltrials.gov

Share:
Add to list

A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

Study ID: NCT07493135
Start Date: 2026-03-31
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

IMV101 treatment

Sponsor

Suzhou Immunofoco Biotechnology Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

Study ID: NCT07424404
Start Date: 2026-03-31
End Date: 2030-03-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

KarXT

Sponsor

Karuna Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Observational Study to Collect Data of Patient Which Recieving a TAVI in TAVI Procedure

Study ID: NCT07215143
Start Date: 2026-04
End Date: 2033-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

IHF GmbH - Institute for Heart Attack Research

Source: clinicaltrials.gov

Share:
Add to list

Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

Study ID: NCT05985135
Start Date: 2026-06-01
End Date: 2028-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Muscle Biopsy

Jell-O with Amino acids

Dextrose

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list